drugset / Trial / NCT00373464
Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery
Phase 3
Completed
126 enrolled
Ullevaal University Hospital
Merck Sharp & Dohme LLC · collabUniversity of Oslo · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
The aim of this trial is to compare if a single dose of oral etoricoxib 120 mg will have equal post-operative analgesic efficacy as an optimal regiment of intravenous ketorolac 30 mg + 30 mg during the first 18 hours (+/- 1 hour) after gynaecologic laparoscopic surgical procedures, where the need for post-operative opioid is expected.
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etoricoxib | Small molecule | 120 mg | Oral |
Indications
No indication recorded.